Prediction of atrial fibrillation recurrence after cardioversion in patients with left-atrial dilation

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 3, 2015, Pages 335-341

  Fornengo, Cristina ^a   Antolini, Marina ^a   Frea, Simone ^a   Gallo, Cristina ^a   Marra, Walter Grosso ^a   Morello, Mara ^a   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Atrial fibrillation; Cardioversion; Diastolic function; Left atrial volume

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CARDIAC PATIENT; CARDIOVASCULAR RISK; CARDIOVERSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHO; FEMALE; FIBRINOLYTIC THERAPY; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE VOLUME; HUMAN; INTERMETHOD COMPARISON; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HYPERTROPHY; INCIDENCE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; ATRIAL FIBRILLATION; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; HYPERTROPHY; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84931561190     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu193     Document Type: Article

References (26)

1. Magnani JW, Rienstra M, Lin H, Sinner MF, Lubitz SA, McManus DD et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011;124:1982-93.
2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012;33:2719-47.
3. Bertaglia E, D'Este D, Zerbo F, Zoppo F, Delise P, Pascotto P. Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. Eur Heart J 2002;23:1522-8.
4. Vizzardi E, Curnis A, Latini MG, Salghetti F, Rocco E, Lupi L et al. Risk factors for atrial fibrillation recurrence: a literature review. J Cardiovasc Med 2014;15:235-53.
5. Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, BarbieriAet al. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011;12:214-21.
6. Nagueh SF, Appleton CP, Gillebert TC, Marino PN,OhJK, SmisethOAet al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiography 2009;22:107-33.
7. Li C, Ding X, Zhang J, Zhou C, Chen Y, Rao L. Does the E/e' index predict the maintenance of sinus rhythm after catheter ablation of atrial fibrillation? Echocardiography 2010;27:630-6.
8. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63.
9. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl. 2):S1-113.
10. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
11. Rosca M, Lancellotti P, Popescu BA, Piérard LA. Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart 2011;97:1982-9.
12. SohnDW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 1999;12:927-31.
13. Agmon Y, Khandheria BK, Gentile F, Seward JB. Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol 1999;34:1867-77.
14. Mor-Avi V, Lang MR, Badano LP, Belohlavek M, Cardim NM, Derumeaux G. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese society of echocardiography. J Am Soc Echocardiogr 2011;24:277-313.
15. Frea S, Bovolo V, Bergerone S, D'Ascenzo F, Antolini M, Capriolo M et al. Echocardiographic evaluation of right ventricular stroke work index in advanced heart failure: a new index? J Card Fail 2012;18:886-93.
16. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT). Am Heart J 2005;149:548-57.
17. Ökçün B, Yigit Z, Serdar Küçükoglu M, Mutlu H, Sansoy V, Güzelsoy D et al. Predictors for maintenance of sinus rhythm after cardioversion in patients with nonvalvular atrial fibrillation. Echocardiography 2002;19:351-7.
18. Disertori M, Lombardi F, Barlera S, Sci M, Latini R, Maggioni AP et al. Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am Heart J 2010;159:857-63.
19. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, O'Hara GE et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2006;151:390-6.
20. Pisters R, Nieuwlaat R, Prins M, Le Heuzey J-Y, Maggioni AP, Camm AJ et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace 2012;14:666-74.
21. Han M, Zhang Y, Sun S,Wang Z,Wang J, Xie X et al. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol 2013;62:405-15.
22. Weiss JN, Qu Z, Chen PS, Lin SF, Karagueuzian HS, Hayashi H et al. The dynamics of cardiac fibrillation. Circulation 2005;112:1232-40.
23. Toso E, Blandino A, Sardi D, Battaglia A, Garberoglio L, Miceli S et al. Electrical cardioversion of persistent atrial fibrillation: acute and long-term results stratified according to arrhythmia duration. Pacing Clin Electrophysiol 2012;35:1126-34.
24. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46.
25. Shah N, Badheka AO, Grover PM, Patel NJ, Chothani A, Mehta K. Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy. Int J Cardiol 2014;174: 288-92.
26. Okura H, Takada Y, Kubo T, Iwata K, Mizoguchi S, Taguchi H et al. Tissue Dopplerderived index of left ventricular filling pressure, E/E' , predicts survival of patients with non-valvular atrial fibrillation. Heart 2006;92:1248-52.